Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW
Watchlist
Compare
6,200.00
-140.00 (-2.21%)
At close: Jun 19, 2025, 3:30 PM KST
Overview
Financials
Statistics
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
2017 - 2019
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2017 - 2019
Contract Manufacturing Organization (CMO)
5.65B
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing Organization (CMO) Growth
254.46%
Log In
Log In
Log In
Log In
Upgrade
EPO Medicine
5.64B
Log In
Log In
Log In
Log In
Upgrade
EPO Medicine Growth
65.43%
Log In
Log In
Log In
Log In
Upgrade
Royalty
1.15B
Log In
Log In
Log In
Log In
Upgrade
Royalty Growth
324.85%
Log In
Log In
Log In
Log In
Upgrade
Technology Transfer (CDO)
623.13M
Log In
Log In
Log In
Log In
Upgrade
Technology Transfer (CDO) Growth
-35.69%
Log In
Log In
Log In
Log In
Upgrade
Other
1.61B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
50.30%
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
2017 - 2019
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2017 - 2019
South Korea
8.87B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
90.53%
Log In
Log In
Log In
Log In
Upgrade
Overseas
5.81B
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
118.17%
Log In
Log In
Log In
Log In
Upgrade